Success Story
Pharmadesk delivered first to file iron sucrose study to USFDA for its client.
Success Story
1% Propofol for EMEA submission was successfully delivered using ICU setup.
Success Story
EMEA granted MA to client with single BE study for oncological product, saving Millions of pounds.
Success Story
Australian authority accepted justification and safety rational for change of salt from succinate to oxalate for desvelafaxine.
Success Story